Myriad RBM will be transferring all RodentMAP Services, effective February 1st 2016 to Ampersand Biosciences.
Rodent MAP services will be transferred to our collaborator and partner Ampersand Biosciences Inc. that was spun out of Myriad RBM in April of 2015. Ampersand Biosciences will begin accepting samples in February for monthly testing beginning on March 1, 2016.
Rodent samples will be accepted at MRBM for testing through Feb. 1, 2016. This difficult decision is based on our need to further direct resources to meet the growing demands for our human clinical research testing services.